Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NaoXinQing
- Development stage
- Unknown
- Lead developer
- Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
NaoXinQing is a Traditional Chinese Medicine (TCM) pharmaceutical product developed and manufactured by Guangzhou Baiyunshan Hutchison Whampoa Traditional Chinese Medicine Co., Ltd. It is a standardized extract derived from the leaves of *Diospyros kaki* L.f. (persimmon leaves), primarily composed of total flavonoids. The drug is indicated for the treatment of cardiovascular and cerebrovascular diseases, most notably ischemic stroke, coronary heart disease, and angina pectoris. Its therapeutic mechanism involves improving cerebral and coronary blood flow, reducing blood viscosity, and inhibiting platelet aggregation. Additionally, NaoXinQing provides neuroprotection by scavenging reactive oxygen species (ROS) and downregulating the expression of inflammatory adhesion molecules such as ICAM-1 and VCAM-1, which helps mitigate damage during ischemia-reperfusion injury.
- Brand names
- NaoXinQing
- Other names
- Persimmon leaf flavonoidsFolium Diospyri Kaki extractNao Xin Qing
02
Targets
ICAM1 (Intercellular Adhesion Molecule 1)VCAM1 (Vascular cell adhesion molecule 1)
Beyond the preview
Go deeper on NaoXinQing.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NaoXinQing.